CALIXAR will be present at the 4th Congress of Immunotherapies & Innovations for Infectious Diseases on December 9-10, 2020

November 24, 2020

CALIXAR is a biotech company specialized in the isolation of native membrane therapeutic targets and antigens. This digital event will be the opportunity to present CALIXAR’s proprietary technologies and know-how to any partner who wants to contribute to generate drugs, antibodies, or vaccines to fight infectious diseases.

About I4ID2020 :

The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach. The I4ID2020 edition will largely address the current COVID-19 pandemics as well as other infectious diseases.

For more information:

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.